A lysosome-targeted drug delivery system based on sorbitol backbone towards efficient cancer therapy

A Controlled-Release Nanocarrier with Extracellular pH Value Driven Tumor Targeting and Translocation for Drug Delivery

(2013) Zilong Zhao et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Targeting therapy of hepatocellular carcinoma with doxorubicin prodrug PDOX increases anti-metastatic effect and reduces toxicity: a preclinical study

(2013) Qun Wang et al.   Journal of Translational Medicine

Three-dimensional cultures modeling premalignant progression of human breast epithelial cells: role of cysteine cathepsins

(2012) Stefanie R. Mullins et al.   BIOLOGICAL CHEMISTRY

Cell-penetrating Peptides as a Novel Transdermal Drug Delivery System

(2012) Saman A. Nasrollahi et al.   Chemical Biology & Drug Design

Differential Impact of Cysteine Cathepsins on Genetic Mouse Models of De novo Carcinogenesis: Cathepsin B as Emerging Therapeutic Target

(2012) Thomas Reinheckel et al.   Frontiers in Pharmacology

Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature

(2010) De-Hong Yu et al.   BIOMATERIALS

Cell-penetrating chitosan/doxorubicin/TAT conjugates for efficient cancer therapy

(2010) Jue-Yeon Lee et al.   INTERNATIONAL JOURNAL OF CANCER

Cell-penetrating peptides: Nanocarrier for macromolecule delivery in living cells

(2010) Archana Chugh et al.   IUBMB LIFE

Extracellular Proteases as Targets for Drug Development

(2009) Mare Cudic et al.   CURRENT PROTEIN & PEPTIDE SCIENCE

Granulysin Induces Cathepsin B Release from Lysosomes of Target Tumor Cells to Attack Mitochondria through Processing of Bid Leading to Necroptosis

(2009) H. Zhang et al.   JOURNAL OF IMMUNOLOGY

The design of guanidinium-rich transporters and their internalization mechanisms

(2007) Paul A. Wender et al.   ADVANCED DRUG DELIVERY REVIEWS